Introduction {#sec1_1}
============

Dome-shaped macula (DSM) is an entity recently described as a convex anterior protrusion of the macular area within a posterior myopic staphyloma \[[@B1]\]. The original description by Gaucher et al. \[[@B1]\] was made out of a group of highly myopic eyes and some vision-threatening complications were specifically described, such as choroidal neovascularization, macular retinal atrophy, flat irregular pigment epithelium deposits, epiretinal membrane, and serous retinal detachment (SRD). SRD physiopathology still remains unclear. Different hypotheses have been proposed. Viola et al. \[[@B2]\] thought that thickened central macular choroid in DSM could lead to choroidal leakage as reported in central serous chorioretinopathy. Choroidal vascular changes in the central zone and specific abrupt choroidal thickness changes between central and peripheral macula \[[@B3]\] may alter choroidal blood flow and trigger SRD development \[[@B3], [@B4]\].

In this clinical case, we describe a patient presenting with DSM associated with epiretinal membrane and SRD. After epiretinal membrane peeling, transient resolution of SRD was noticed, suggesting that vitreous removal had influenced SRD evolution.

Case Report {#sec1_2}
===========

We report a case of a 63-year-old woman presenting with a decreased vision and metamorphopsia. Her best-corrected visual acuity (BCVA) on the right eye was 20/50. The axial length was 24.4 mm and spherical equivalent was −5.

The initial OCT horizontal scan showed a macular bulge with a maximal height of 760 µm measured as previously described \[[@B5], [@B6]\] (Fig. [1](#F1){ref-type="fig"}). On the vertical scan, there was no macular bulge: the horizontal axis was the most cambered on SD-OCT, indicating that this DSM had a vertical oval-shaped pattern \[[@B6]\]. An SRD was present and an epiretinal membrane could also be observed on both vertical and horizontal OCT scans on Spectralis HRA OCT® (Heidelberg Engineering, Heidelberg, Germany) (Fig. [1](#F1){ref-type="fig"}).

Fluorescein angiography (FA) and indocyanine green angiography (ICGA) showed hypofluorescent and hypocyanescent perifoveal zones without any leakage or choroidal neovascularization. Infrared image showed multiples epicenters of contraction leading to retinal folds (Fig. [2](#F2){ref-type="fig"}).

Epiretinal membrane peeling was performed as vision was decreasing since the last control 6 months before. One month after surgery, we observed a progressive decrease of SRD and a complete resolution of subretinal fluid at 3 months (Fig. [3](#F3){ref-type="fig"}). However, SRD reappeared 1 year after surgery and enlarged within 2 years following surgery (Fig. [3](#F3){ref-type="fig"}).

Discussion {#sec1_3}
==========

Several studies showed the presence of SRD in patients presenting with DSM \[[@B1], [@B2], [@B6], [@B7], [@B8]\]. Different hypotheses were advanced to explain SRD appearance. In a robust study, Viola et al. \[[@B2]\] noted that there was more pinpoint leakage on FA and hypercyanescent choroidal points on ICGA in eyes with SRD than without. These findings showed similarities with chronic central serous chorioretinopathy.

In our clinical case, this leakage on FA and ICGA was not present. The fact that vitrectomy and epiretinal membrane peeling could improve transiently the SRD may suggest two mechanisms for SRD physiopathology: first, the epiretinal membrane may have exerted traction on the macular retina, favoring the apparition of SRD. Second, the vitreous body might constitute a tank for cytokines and/or other factors, triggering subretinal fluid accumulation and finally leading to SRD formation.

Some authors noted a variation of choroidal thickness between peripheral and central macular areas in a case series \[[@B3]\]: they suggested that this difference could increase choroid hydrostatic pressure leading to SRD. However, we did not find significant results in SRD subgroups, in a series comparing choroidal thickness in DSM and no-DSM groups \[[@B4]\]. Furthermore, the different treatments usually used for hematoretinal barrier restoration (i.e., eplerenone, spironolactone, photodynamic therapy, anti-VEGFs, etc.) seemed inefficient, suggesting other mechanisms than external blood barrier disruption \[[@B5], [@B8]\]. Even if spontaneous resolution has been observed in a certain proportion of cases \[[@B5]\], the sequence of events in this case strongly suggests a role for vitrectomy in the transient disappearance of SRD. This evolution of fluid movements following vitrectomy has already been observed in macular edema pathology \[[@B9]\]. The removal of the vitreous body may have decreased the level of some factors causing SRD. Oxygen and other factors regulating the external blood retinal barrier may then be implicated. Recently, spironolactone has been shown to have sometimes positive effects on SRD in DSM \[[@B10]\]. Aldosterone or other effectors of aldosterone receptors may be present in the vitreous; their removal during vitrectomy might be responsible for transient decrease of SRD in this case.

Conclusion {#sec1_4}
==========

SRD is a common complication in DSM, in which treatment management is a difficult task. Vitrectomy seems to play a role for transient resolution of SRD associated with DSM. The mechanisms of this effect are unclear; SRD may be due to the surgical removal of factors triggering subretinal fluid accumulation.
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![The initial OCT horizontal scan showed a macular bulge with a maximal height of 760 µm measured (**a**). On the vertical scan, there was no macular bulge: the horizontal axis was the most cambered on SD-OCT Spectralis HRA OCT® (Heidelberg Engineering, Heidelberg, Germany), indicating that this DSM had a vertical oval-shaped pattern (**b**). An SRD was present and an epiretinal membrane could also be observed on both vertical and horizontal OCT scans.](cop-0008-0515-g01){#F1}

![Both fluorescein angiography (**a**) and indocyanine green angiography (**b**) showed hypofluorescent and hypocyanescent perifoveal zones without any leakage or pinpoints. Infrared image showed multiple epicenters of contraction leading to retinal folds (**c**).](cop-0008-0515-g02){#F2}

![One month after surgery, we observed a progressive decrease of SRD (**a**), and a complete resolution of subretinal fluid at 3 months (**b**). However, SRD reappeared 1 year after surgery (**c**) and enlarged within 2 years following surgery (**d**).](cop-0008-0515-g03){#F3}
